Insights from AANEM 2025, including anticipated presentations, key takeaways, and how emerging research in myasthenia gravis ...

Dr Katherine Ruzhansky previews presentations on biomarkers, new therapies, and translational science at AANEM 2025.

Drs Joseph Mikhael and Peter Voorhees discuss considerations for treating smoldering multiple myeloma, including recent ...

MariTide is now progressing into phase 3 trials, with a focus on its long-term safety and efficacy. Amgen expects to apply ...

GLP-1s can cause changes in hydration, nutrition, and GI function that directly affect the mouth. Aminoshariae said these ...

Two phase 3 trials suggest that the antibody drug conjugate led to significantly improved outcomes in both the neoadjuvant ...

Researchers have developed a hydrogel that lasts longer than current treatments for vocal fold disorders and could reduce the ...

Against Medical Advice’ discharge notes often include stigmatizing language, with providers expressing anger and judgment.

The recommendations aim to reduce unnecessary ‘cumbersome’ testing and improve antibiotic stewardship in sore throat ...

Healthcare renunciation during the COVID-19 pandemic is seen among older adults in Italy and tied to sex and economic ...

A comparative effectiveness study of glucose-lowering drugs finds the GLP-1 receptor agonists most protective against ...

Researchers have devised a new way to illuminate the previously invisible oligomer clumps driving Parkinson’s disease.